At UiPath’s Fusion London event, NFU Mutual’s automation lead explains how the UK insurer built a working agentic claims process, found overpayments humans missed, and built a credible business case.
UiPath (NYSE:PATH) executives used the company’s latest earnings call question-and-answer session to emphasize what they ...
UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced financial results for its fourth quarter and full year fiscal 2026 ended January 31, 2026.
UiPath closes fiscal year 2026 on a high, with co-Founder and CEO Daniel Dines making a bold case that falling AI development costs are good for the automation market, not a threat to it.
UiPath PATH is pushing deeper into agentic automation, aiming to move beyond task-level robotic process automation into systems that can reason, plan, and execute across workflows. The strategy is ...
UiPath PATH shares are trading higher on Wednesday. The company recently achieved AIUC 1 certification, setting a new standard for AI agent security and reliability. • How is PATH stock doing now?
Zacks Investment Research on MSN
UiPath's AI automation model is driving platform-level efficiency
UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...
Learn how PPC automation layering combines Smart Bidding, scripts, AI tools, and human strategy to improve campaign efficiency, oversight, and long-term performance.
UiPath (PATH) stock slides after Q4 FY26 results as Needham upgrades to Buy on ARR and free cash flow growth; AI ARR hits $200M.
Dines spotlighted Maestro, UiPath's orchestration engine, and recent product wins, including a semiconductor company deploying agentic workflows in under two weeks and One New Zealand, which reduced a ...
UiPath reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for a slowdown in full-year revenue growth.
Stocktwits on MSN
UiPath’s AI automation story is not translating into faster growth yet, say UBS, Morgan Stanley analysts
Morgan Stanley analyst Sanjit Singh also trimmed his price target to $17 from $19. ・Analysts say fourth-quarter results met expectations but see limited near-term upside due to modest growth. ・UBS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results